A rotavirus vaccine candidate showed better efficacy than Merck’s and GlaxoSmithKline’s approved vaccines in a late-stage trial.

The CDC is preparing a new avian influenza vaccine candidate amid an outbreak in China.

Takeda has partnered with digital health tools venture Cognition Kit to collect active and passive patient data for a deep dive on depression.

Astellas just forged a licensing deal with Affinivax to develop a pneumococcal vaccine. Their target? Pfizer’s Prevnar 13—the world’s best-selling vaccine.

WuXi AppTec subsidiary STA has bulked up with a new pilot plant and a fresh batch of R&D scientists trained at the company’s Shanghai R&D site.

Sun Pharma has snapped up Ocular Technologies from Auven Therapeutics, adding to its growing eyecare medicines pipeline.

It's become well-recognized that pharma companies need to move beyond the "not invented here" mindset and tap into the scientific expertise of…

Daiichi Sankyo licenses two abuse-deterrent painkillers from Inspirion to further its pain-management ambitions.

R&D